-
EP1940417
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP1940417
| EP1940417 - METHOD OF TREATING CLOSTRIDIUM DIFFICILE-ASSOCIATED DIARRHEA [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 03.06.2016 Database last updated on 15.07.2024 | Most recent event Tooltip | 03.06.2016 | Application deemed to be withdrawn | published on 06.07.2016 [2016/27] | Applicant(s) | For all designated states Merck Sharp & Dohme Corp. 126 East Lincoln Avenue Rahway, NJ 07065 / US | [2015/41] |
| Former [2013/41] | For all designated states Optimer Pharmaceuticals, Inc. 101 Hudson Street Suite 3501 Jersey City, NJ 07302 / US | ||
| Former [2008/28] | For all designated states Optimer Pharmaceuticals, Inc. 10110 Sorrento Valley Road, Suite C San Diego, CA 92121 / US | Inventor(s) | 01 /
SEARS, Pamela 11883 Spruce Run Drive No. C San Diego, CA 92131 / US | 02 /
SHUE, Youe-Kong 7869 Via Teca Carlsbad, CA 92009 / US | 03 /
MILLER-SHANGLE, Starr, Louise 4449 Conrad Avenue San Diego, CA 92117 / US | 04 /
WALSH, Robert, Brian 377 Sandpiper Drive Davis, CA 95616 / US | 05 /
BABAKHANI, Farah 10955 Elderwood Road San Diego, CA 92131 / US | 06 /
CHIU, Yu-Hung 10615 Dabney Drive No. 20 San Diego, CA 92126 / US | 07 /
ROMERO, Alex 2219 Howard Avenue San Diego, CA 92104 / US | 08 /
GORBACH, Sherwood 31 Perry Lane Weston, MA 02493 / US | 09 /
LOUIE, Thomas, John 25 Bearspaw Point Way Calgery, Aberta T3L 296 / CA | [2008/28] | Representative(s) | Oates, Edward Christopher, et al Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB | [2014/18] |
| Former [2013/37] | Potter Clarkson LLP The Belgrave Centre Talbot Street Nottingham NG1 5GG / GB | ||
| Former [2011/14] | Stevens, Ian Edward, et al Potter Clarkson LLP Park View House 58 The Ropewalk Nottingham NG1 5DD / GB | ||
| Former [2008/28] | Ziebig, Marlene, et al Anwaltskanzlei Gulde Hengelhaupt Ziebig & Schneider Wallstrasse 58/59 10179 Berlin / DE | Application number, filing date | 06826544.6 | 23.10.2006 | [2008/28] | WO2006US41436 | Priority number, date | US20050729135P | 21.10.2005 Original published format: US 729135 P | US20050749641P | 12.12.2005 Original published format: US 749641 P | [2008/28] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2007048059 | Date: | 26.04.2007 | Language: | EN | [2007/17] | Type: | A2 Application without search report | No.: | EP1940417 | Date: | 09.07.2008 | Language: | EN | The application published by WIPO in one of the EPO official languages on 26.04.2007 takes the place of the publication of the European patent application. | [2008/28] | Search report(s) | International search report - published on: | US | 31.05.2007 | (Supplementary) European search report - dispatched on: | EP | 09.06.2010 | Classification | IPC: | A61K31/70, A61K45/06, A61P31/04 | [2010/27] | CPC: |
A61K31/70 (EP,KR);
A61P1/00 (EP);
A61P1/04 (EP);
A61P1/12 (EP);
A61P31/04 (EP)
|
| Former IPC [2008/28] | A61K31/70 | Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR [2008/28] | Title | German: | VERFAHREN ZUR BEHANDLUNG VON DIARRHOE IM ZUSAMMENHANG MIT CLOSTRIDIUM DIFFICILE | [2008/28] | English: | METHOD OF TREATING CLOSTRIDIUM DIFFICILE-ASSOCIATED DIARRHEA | [2008/28] | French: | MÉTHODE DE TRAITEMENT D'UNE DIARRHÉE ASSOCIÉE À CLOSTRIDIUM DIFFICILE | [2008/28] | Entry into regional phase | 25.04.2008 | National basic fee paid | 25.04.2008 | Search fee paid | 25.04.2008 | Designation fee(s) paid | 25.04.2008 | Examination fee paid | Examination procedure | 25.04.2008 | Examination requested [2008/28] | 05.01.2011 | Amendment by applicant (claims and/or description) | 02.03.2011 | Despatch of a communication from the examining division (Time limit: M04) | 27.06.2011 | Reply to a communication from the examining division | 22.07.2015 | Despatch of a communication from the examining division (Time limit: M06) | 02.02.2016 | Application deemed to be withdrawn, date of legal effect [2016/27] | 02.03.2016 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2016/27] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 02.03.2011 | Fees paid | Renewal fee | 29.10.2008 | Renewal fee patent year 03 | 28.10.2009 | Renewal fee patent year 04 | 27.10.2010 | Renewal fee patent year 05 | 25.10.2011 | Renewal fee patent year 06 | 11.10.2012 | Renewal fee patent year 07 | 30.10.2013 | Renewal fee patent year 08 | 27.10.2014 | Renewal fee patent year 09 | 07.10.2015 | Renewal fee patent year 10 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [I]US5583115 (MCALPINE JAMES B [US], et al) [I] 1-15 * abstract ** claims 1-17 *; | [XP]WO2005112990 (OPTIMER PHARMACEUTICALS INC [US], et al) [XP] 1-3,6-14 * abstract * * page 9, line 14 - line 17 * * page 17 - page 18 * * claims 1-57 *; | [XP]WO2006085838 (OPTIMER PHARMACEUTICALS INC [US], et al) [XP] 1-3,6-15 * abstract * * claims * * page 9, line 17 - line 26 * | International search | [Y] - SWANSON R.N. ET AL, "In vitro and in vivo evaluation of tiacumicins B and C against Clostridium difficile", ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, (199106), vol. 35, no. 6, pages 1108 - 1111, XP003012680 |